In their report of a patient recently infected with a multidrug-resistant HIV-1, Martin Markowitz and colleagues

The Lancet

Volumn 365, Issue 9475, 2005, Pages 1924-1925

  Nixon, Douglas F ^a   Deeks, Steven G ^b   Shacklett, Barbara L ^c   Karlsson, Annika C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

DISEASE COURSE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MULTIDRUG RESISTANCE; NOTE; VIROLOGY;

AIDS VACCINES; DISEASE PROGRESSION; DRUG RESISTANCE, MULTIPLE, VIRAL; EPITOPES; HIV INFECTIONS; HIV-1; HUMANS;

EID: 24044480691     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)66653-6     Document Type: Letter

References (5)

1. M Markowitz, H Mohri, S Mehandru et al. Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report Lancet 365 2005 1031 38
2. SG Deeks Treatment of antiretroviral-drug-resistant HIV-1 infection Lancet 362 2003 2002 11
3. A Samri, G Haas, J Duntze et al. Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells J Virol 74 2000 9306 12
4. AC Karlsson, SG Deeks, JD Barbour et al. Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene J Virol 77 2003 6743 52
5. RD Mason, MI Bowmer, CM Howley, M Gallant, JC Myers, MD Grant Antiretroviral drug resistance mutations sustain or enhance CTL recognition of common HIV-1 Pol epitopes J Immunol 172 2004 7212 19